Summary of Prices in US$ quoted by companies for eligible developing countries

The price in brackets corresponds to the price of one unit (tablet, capsule, etc.).
Products included in the WHO List of Prequalified Medicinal Products (as of April 2010) are in bold.

ARVs in alphabetical order Daily dose Originator company
Generic companies
Abacavir (ABC) ViiV Aurobindo Cipla Hetero Matrix Ranbaxy Strides
20mg/ml oral solution 10ml 230 (0.063/ml) 212 (0.058/ml) 113 (0.031/ml)      
60mg tablet 4   153 (0.105) 134 (0.092)   183 (0.125)
300mg tablet 2 438 (0.600) 243 (0.333) 207 (0.283) 256 (0.350) 219 (0.300) 274 (0.375) 540 (0.370)
Atazanavir (ATV)* Daily dose
Originator company
Generic companies
BMS
 Matrix
Category 1 countries Category 2 countries
150mg capsule 2 353 (0.484) 431 (0.590)  
200mg capsule xx (0.602) (0.743)  
300mg capsule 1     256 (0.700)
Darunavir (DRV)* Daily dose
Originator company
Tibotec
300mg tablet 2 1095 (0.750)
Didanosine (ddI) Daily dose
Originator company
Generic companies
BMS
 Aurobindo Cipla Ranbaxy
Category 1 countries Category 2 countries
2g powder for reconstitution (final concentration 10mg/ml) 12 ml 276 (12.590/2g) 308 (14.057/2g) 88 (4.000/2g)    
25mg tablet 5 212 (0.116) 429 (0.235) 115 (0.063) 228 (0.125)
50mg tablet xx (0.158) (0.235)   (0.079) (0.115)
100mg tablet 4 311 (0.213) 364 (0.249) 194 (0.133) 188 (0.129) 242 (0.166)
125mg enteric-coated
capsule		 1   110 (0.300)  
150mg tablet xx (0.308) (0.345) (0.225) (0.167)
200mg tablet xx (0.267) (0.257)
200mg enteric-coated
capsule		 xx     (0.383)  
250mg enteric-coated
capsule		 1 223 (0.611) 249 (0.683) 170 (0.467) 103 (0.283)  
400mg enteric-coated
capsule		 1 288 (0.789) 322 (0.881) 256 (0.700) 132 (0.363)
Efavirenz (EFV) Daily dose
Originator company
Generic companies
Merck
 Aurobindo Cipla Hetero Matrix Ranbaxy Strides
Category 1 countries Category 2 countries
30mg/ml suspension xx (0.094/ml) (0.151/ml)  
50mg capsule xx     (0.083) (0.083)
50mg tablet xx (0.120) (0.210)  
100mg capsule xx     (0.150)    
200mg capsule 3     130 (0.119) 134 (0.122) 152 (0.139) 118 (0.108)  
200mg tablet 3 3 394 (0.360) 821 (0.750)       146 (0.133)   110 (0.100)
600mg tablet 1 1 237 (0.650) 657 (1.800) 73 (0.200) 79 (0.217) 82 (0.225) 61 (0.167) 91 (0.250) 62 (0.170)
Emtricitabine (FTC) Daily dose
Generic companies
Aurobindo Matrix
200mg capsule 1 63 (0.173) 79 (0.217)
Etravirine (ETV) Daily dose Originator company
Tibotec
100mg tablet 4 913 (0.625)
Fosamprenavir (FPV)* Daily dose
Originator company
ViiV
50mg/ml suspension 12ml 648 (0.148/ml)
700mg tablet 2 1222 (1.674)
Indinavir (IDV)* Daily dose
Originator company
Generic companies
Merck
 Aurobindo Cipla Hetero
Category 1 countries Category 2 countries
400mg capsule 4 394 (0.270) 686 (0.470) 292 (0.200) 422 (0.289) 390 (0.267)
Lamivudine (3TC) Daily dose
Originator company
Generic companies
ViiV Aurobindo Cipla Hetero Matrix Ranbaxy Strides
10mg/ml suspension 10ml 84 (0.023/ml) 29 (0.008/ml) 37 (0.010/ml) 37 (0.010/ml)
150mg tablet 2 64 (0.087) 34 (0.047) 35 (0.048) 33 (0.045) 34 (0.046) 34 (0.047) 37 (0.050)
300mg tablet 1   24 (0.067) 41 (0.113) 38 (0.103) 34 (0.092)
Lopinavir/
ritonavir (LPV/r)		 Daily dose
Originator company
Generic companies
Abbott
 Aurobindo Cipla Hetero Matrix
Category 1 countries Category 2 countries
80/20mg/ml
oral solution		 4 ml 176 (0.121/ ml) 400 (0.274/ ml)        
100/25mg heat-stable
tablet		 3 165 (0.151) 376 (0.343) 219 (0.200)     228 (0.208)
133/33mg soft-gel capsule 6 500 (0.228) 1000 (0.457)   609 (0.278)    
200/50mg heat-stable tablet 4 440 (0.301) 1000 (0.685) 475 (0.325) 463 (0.317) 493 (0.338) 486 (0.333)
Nelfinavir (NFV) Daily dose
Originator company
Generic companies
Roche
 Cipla
Category 1 countries Category 2 countries
50mg/g oral powder 24g 2129 (0.243/g) 2462 (0.281/g)  
250mg tablet 10 1566 (0.429) 2427 (0.665) 945 (0.259)
Nevirapine (NVP) Daily dose
Originator company
Generic companies
Boehringer
 Aurobindo Cipla Hetero Huahai Matrix Ranbaxy Strides
Category 1 countries Category 2 countries
10mg/ml suspension 20ml 380 (0.052/ml) 533 (0.073/ml) 66 (0.009/ml) 73 (0.010/ml)
200mg tablet 2 219 (0.300) 438 (0.600) 39 (0.054) 34 (0.046) 37 (0.050) 34 (0.047) 39 (0.054) 39 (0.053) 37 (0.050)
RAL Daily dose Merck
Category 1
400mg tablet 2 1113 (1.525)
Raltegravir (RAL) Daily dose
Originator company
Merck
Category 1 countries
400mg tablet 2 1113 (1.525)
80mg/ml oral solution xx (0.093/ml)
Ritonavir (RTV) Daily dose
Originator company
Generic companies
Category 1 countries Cipla
Abbott
100mg soft-gel capsule 2 83 (0.114) 313 (0.429)
100mg heat-stable tablet 2 83 (0.114)
Saquinavir (SQV)* Daily dose
Originator company
Generic companies
Roche
 Cipla
Category 1 countries Category 2 countries
200mg hard capsule 10 1212 (0.332) 2427 (0.665) 1621 (0.444)
500mg tablet 4 1113 (0.762) 2427 (1.662)  
Stavudine (d4T) Daily dose
Originator company
Generic companies
BMS
 Aurobindo Cipla Hetero Matrix Ranbaxy Strides
Category 1 countries Category 2 countries
1mg/ml powder for suspension 20ml 51 (0.007/ml) 58 (0.008/ml) 58 (0.008/ml) 44 (0.006/ml)
15mg capsule xx (0.082) (0.093) (0.026) (0.024) (0.025)
20mg capsule xx (0.089) (0.093) (0.027) (0.025) (0.028)
30mg capsule 2 48 (0.066) 68 (0.093) 20 (0.028) 26 (0.035) 21 (0.029) 24 (0.033) 26 (0.035) 22 (0.030)
<
Tenofovir (TDF) Daily dose
Originator company
Generic companies
Gilead
 Aurobindo Cipla Hetero Matrix Ranbaxy Strides
Category 1 countries Category 2 countries
300mg tablet 1 204 (0.559) 360 (0.986) 100 (0.275) 87 (0.237) 103 (0.283) 85 0.233) 152 (0.417) 146 (0.400)
Zidovudine (AZT) Daily dose Originator company
Generic companies
ViiV Aurobindo Cipla Hetero Matrix Ranbaxy
10mg/ml oral solution 20 ml 234 (0.032/ml) 66 (0.009/ml) 80 (0.011/ml) 66 (0.009/ml)    
60mg tablet 4   115 (0.079)        
100mg capsule xx (0.122) (0.051) (0.050)  
250mg capsule xx (0.276)  
300mg tablet 2 161 (0.221) 101 (0.138) 97 (0.133) 100 (0.137) 91 (0.125) 91 (0.125)
   
Originator company
Generic companies
ABC/3TC Daily dose ViiV Aurobindo Cipla Matrix
60/30mg tablet 4   175 (0.120) 244 (0.167)
600/300mg tablet 1 484 (1.326) 134 (0.367) 152 (0.417)  
3TC/d4T Daily dose
Generic companies
Aurobindo Cipla Hetero Matrix Ranbaxy Strides
30/6mg dispersable tablet 4 47 (0.032)
60/12mg dispersable tablet 2 40 (0.055)
150/30mg tablet 2 50 (0.068) 42 (0.057) 51 (0.070) 42 (0.058) 42 (0.058) 44 (0.060)
3TC/d4T/NVP Daily dose
Generic companies
Aurobindo Cipla Hetero Matrix Ranbaxy Strides
30/6/50mg dispersible
tablet		 4 55 (0.038)
60/12/100mg dispersible
tablet		 2 53 (0.072)
150/30/200mg tablet 2 67 (0.092) 67 (0.092) 73 (0.100) 67 (0.092) 70 (0.096) 73 (0.100)
3TC/d4T + EFV Daily dose
Generic companies
Cipla Ranbaxy Strides
150/30 + 600mg tablets
(co-pack)		 1 kit (3 tabs) 274 (0.751) 304 (0.833) 106 (0.290)
TDF/FTC Daily dose
Originator company
Generic companies
Gilead
 Aurobindo Cipla Hetero Matrix
Category 1 countries Category 2 countries
300/200mg tablet 1 315 (0.863) 540 (1.479) 155 (0.425) 158 (0.433) 164 (0.450) 143 (0.392)
TDF/FTC/EFV Daily dose
Originator company
Generic companies
Gilead
 Cipla Matrix
Category 1 countries Category 2 countries
300/200/600mg tablet 1 613 (1.680) 1033 (2.830) 268 (0.733) 219 (0.600)
TDF/3TC Daily dose
Generic companies
Cipla Hetero Matrix
300/300mg tablet 1 122 (0.333) 128 (0.350) 107 (0.294)
AZT/3TC Daily dose Originator company
Generic companies
ViiV Aurobindo Cipla Hetero Matrix Ranbaxy Strides
60/30mg tablet 4   95 (0.065) 121 (0.083) 88
(0.060)
300/150mg tablet 2 197 (0.270 112 (0.154) 111 (0.152) 115 (0.158) 110 (0.150) 110 (0.150) 131 (0.180)
AZT/3TC/ABC Daily dose Originator company
Generic companies
ViiV Cipla Matrix Ranbaxy
60/30/60mg tablet 4     244 (0.167)  
300/150/300mg tablet 2 653 (0.895) 414 (0.567) 365 (0.500) 548 (0.750)
AZT/3TC/NVP Daily dose
Generic companies
Aurobindo Cipla Hetero Matrix Ranbaxy Strides
60/30/50mg dispersible tablet 4     158 (0.108) 183 (0.125)  
300/150/200mg dispersible tablet 2 148 (0.203) 137 (0.188) 155 (0.213) 143 (0.196) 145 (0.199) 139 (0.190)
AZT/3TC + EFV Daily dose
Generic companies
Aurobindo Cipla Ranbaxy Strides
300/150 + 600mg tablets(co-pack) 4 231 (0.633) 320 (0.877) 322 (0.883) 189 (0.517)

*The required addition of RTV as a booster must also be considered in the final cost of this drug.